Marco Salvetti

Pubblicazioni

Titolo	Pubblicato in	Anno
Steps towards collective sustainability in biomedical research	TRENDS IN MOLECULAR MEDICINE	2018
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND). a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension	LANCET NEUROLOGY	2018
Collaboration between a human group and artificial intelligence can improve prediction of multiple sclerosis course. A proof-of-principle study	F1000RESEARCH	2018
Chapter 3 - Bacille Calmette-Guérin (BCG) Vaccine in Neuroinflammation	The Value of BCG and TNF in Autoimmunity	2018
Leptomeningitis in a person with radiologically isolated syndrome and latent tuberculosis. A case report with implications for clinical research	JOURNAL OF MEDICAL IMAGING AND CASE REPORTS.	2018
Environmental modifiable risk factors for multiple sclerosis. Report from the 2016 Ectrims focused workshop	MULTIPLE SCLEROSIS	2018
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis. An Italian, Multicenter, Real-World Study	CNS DRUGS	2018
Evaluation woes. Start right	NATURE	2018
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis	JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY	2018
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patients	JOURNAL OF NEUROIMMUNOLOGY	2018
070 Baseline characteristics and safety profile of patients with relapsing-remitting multiple sclerosis (RRMS) in the first interim analysis of the peginterferon BETA-1A treatment in the phase 4 plegridy observational program (POP)	JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY	2018
The Italian multiple sclerosis register	NEUROLOGICAL SCIENCES	2018
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study	JOURNAL OF NEUROLOGY	2018
Bridging the gap between vaccination with Bacille Calmette-Guérin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosis	CURRENT OPINION IN IMMUNOLOGY	2018
A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis	FRONTIERS IN NEUROLOGY	2018
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML	NEUROLOGY	2017
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials	SCIENTIFIC REPORTS	2017
Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients	MULTIPLE SCLEROSIS	2017
Coincident onset of multiple sclerosis and herpes simplex virus 1 encephalitis. a case report	MULTIPLE SCLEROSIS AND DEMYELINATING DISORDERS	2017
Chemical Elements and Oxidative Status in Neuroinflammation	Biometals in Neurodegenerative Diseases. Mechanisms and Therapeutics	2017

Pubblicazioni

Progetti di Ricerca